Search Result "antituberculous effects"
Experimental and Clinical Studies on Rifacinna® - The New Effective Antituberculous Drug (Review)
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 5 Issue: 1 Year: 2010 Page: 76-90
Author(s): Dimova Velichka, Atanasova Ivana, Tomioka Haruaki, Sato Katsumasa, Reddy Venkata, Geeta Nadadhur, Daneluzzi Donna, Gangadharam Patisapu, Kantardjiev Todor, Dhople Arvind, Feshchenko Yurii, Yashina Ljudmila, Toumanov Andrei, Zhivkova Zvetana, Sano Chiaki
Development of New Antituberculous Drugs: Strategies for New Drug Targets and Drug Delivery
Journal: Drug Design Reviews - Online (Discontinued)
Volume: 2 Issue: 6 Year: 2005 Page: 427-434
Author(s): Haruaki Tomioka
The Role of Surrogate Markers in the Clinical Evaluation of Antituberculous Chemotherapy
Journal: Current Medicinal Chemistry - Anti-Infective Agents
Volume: 4 Issue: 4 Year: 2005 Page: 287-294
Author(s): Robert S. Wallis, John L. Johnson
Novel Agents in the Management of Mycobacterium Tuberculosis Disease
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2007 Page: 2000-2008
Author(s): P.J. Barry, T.M. OConnor
Towards the Design and Development of Agents with Broad Spectrum Chemotherapeutic Properties for the Effective Treatment of HIV / AIDS
Journal: Current Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2003 Page: 1689-1695
Author(s): Dharmarajan Sriram, Perumal Yogeeswari
Editorial (Thematic Issue: Current Status and Perspective on Drug Targets in Tubercle Bacilli and Drug Design of Antituberculous Agents Based on Structure-Activity Relationship)
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 2 Year: 2014 Page: 4305-4306
Author(s): Haruaki Tomioka
New Patentable Use of an Old Neuroleptic Compound Thioridazine to Combat Tuberculosis: A Gene Regulation Perspective
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 6 Issue: 2 Year: 2011 Page: 128-138
Author(s): Noton K. Dutta, Kaushiki Mazumdar, Sujata G. Dastidar, Petros C. Karakousis, Leonard Amaral
Clinical Pharmacology and Lesion Penetrating Properties of Second- and Third-Line Antituberculous Agents Used in the Management of Multidrug-Resistant (MDR) and Extensively-Drug Resistant (XDR) Tuberculosis
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 2 Year: 2010 Page: 96-114
Author(s): Veronique Dartois, Clifton E. Barry
Management of Adult Active Tuberculosis Disease in Era of HIV Pandemic, Current Practices and Future Perspectives
Journal: Infectious Disorders - Drug Targets
Volume: 11 Issue: 2 Year: 2011 Page: 134-143
Author(s): Jean B. Nachega, Bernd Rosenkranz, Gary Simon, Richard E. Chaisson, Andreas H. Diacon, Jantjie Taljaard
Drug Susceptibility of the Mycobacterium Genus: In Vitro Tests and Clinical Implications
Journal: Current Clinical Pharmacology
Volume: 1 Issue: 3 Year: 2006 Page: 277-289
Author(s): J. C. Rodriguez, E. Garcia-Pachon, M. Ruiz, G. Royo